⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 2, 2024

[Analysis of predictive effect of European treatment and outcome study long term survival score on survival outcomes in children with chronic myeloid leukemia of chronic phase].

Fuyuan Zheng Ruzhi Deng Airu Lu Yan‐Zeng Jia Hao Zeng L P Zhang Qian Jiang

View at Publisher

Ask AI

Bookmark

Share

Abstract

To explore the predictive effect of European treatment and outcome study long term survival (ELTS) score on survival outcomes in chronic myeloid leukemia of chronic phase (CML-CP) children.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zheng et al. (2024) studied this question.

synapsesocial.com/papers/68e55ff7e2b3180350efcadf https://doi.org/10.3760/cma.j.cn112140-20240130-00085

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The EUTOS long‐term survival score predicts disease‐specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice‐based cohortDecision Analysis · 2020 · 35 citations
2Prognostic utility of the ELTS score in pediatric chronic myeloid leukemia: Is it a valid clinical tool?2025
3The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemiaPrognostic Study · 2020 · 96 citations
4ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CMLCohort Study · 2026
5Early molecular kinetics to predict deep molecular response and inform frontline TKI selection in pediatric chronic myeloid leukemia: A real-world multicenter study.Cohort Study · 2026

More related papers

Impact of Molecular and Cytogenetic Responses on Long-Term Outcomes in Children and Adolescents With Chronic Myeloid Leukemia: A Retrospective Study From India2025
Chronic myeloid leukemia outcomes according to baseline risk and first‐line treatment in real‐world settings: Data from the Italian Network/CML Campus2025
Low initial hemoglobin and high-risk additional chromosomal abnormalities predict poor long-term survival in chronic phase chronic myeloid leukemia2026